|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/68 | (2017.01) |
| A61K 47/65 | (2017.01) | ||
| A61P 39/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07D 487/04 | (2006.01) | ||
| C07D 519/00 | (2006.01) |
| (11) | Number of the document | 2839860 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14191079.4 |
| Date of filing the European patent application | 2013-10-11 | |
| (97) | Date of publication of the European application | 2015-02-25 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-01 |
| (46) | Date of publication of the claims translation | 2019-07-10 |
| (30) | Number | Date | Country code |
| 201261712928 P | 2012-10-12 | US |
| (72) |
Howard, Philip Wilson, GB
|
| (73) |
MedImmune Limited,
Milstein Building Granta Park, Cambridge CB21 6GH,
GB
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pirolobenzodiazepinai ir jų konjugatai |
| Pyrrolobenzodiazepines and conjugates thereof |
| Payment date | Validity (years) | Amount | |
| 2025-09-23 | 13 | 289.00 EUR |
| 2026-10-11 |